3611bda0297945218300d9a34a5524cf.ppt
- Количество слайдов: 9
PSM Technical Briefing Seminar: Day One report From 3 by 5 to Universal Access Information flow key for programs involving chronic management: need for strategic information sharing on PSM at national level Need to invest in the health care delivery systems Opportunity to develop pharmaceutical sector Build on existing capacity HR: Task shifting training HR for additional responsibilities Increasing lead times with increasing chances of wastage: need for companies to invest in increased production
PSM Technical Briefing Seminar: Day One report From 3 by 5 to Universal access Harmonization of country level PSM planning, budgeting and reporting Universal access should address a package of continuum of care: prevention, treatment and care for all who need it. Countries could set own targets.
PSM Technical Briefing Seminar: Day One report GDF – role in Universal access to TB treatment Addressing increasing demand of raw materials for TB drugs Need to support and encourage R&D for development of new molecules NRAs have final say on what can be imported in the countries Harmonization of management of consultants through audit reports
PSM Technical Briefing Seminar: Day One report MMSS – role in Universal access to Malaria Rx Short shelf life of ACTs Quantification and Forecasting constraints Controversial Mo. U between WHO and Novartis – to get low priced supplies of ACTs Presence of only one pre-qualified supplier of ACTs GF accepts procurement of products pre-qualified by WHO or any other stringent NRA in ICH/PICS countries Issue of making ACTs available through private sector was discussed Debate on the need for continued production of monotherapy artemisinin derivatives while shifting to ACTs No sufficient data on safe use of ACTs in pregnancy- SP still use despite resistance
PSM Technical Briefing Seminar: Day One report GFATM PSM Plan Key principles: transparent and competitive procurement Best prices available Follow international and national laws Ensure product quality – WHO pre-qualified, ICH/PICS approved PSM plans to be ready before grant signing PSM plans can be reviewed as long the budget ceiling does not change Countries are encouraged to include TA in their plans
PSM Technical Briefing Seminar: Day One report Price Reporting Mechanisms GF requires countries to report price and sources of products bought using GFATM funds Prices of innovator medicines are publicly available unlike generics Weak reporting from country level procurement to AMDS PRM Plea: share PRM with clients but ask them to report to AMDS PRM currently only for ARVs
PSM Technical Briefing Seminar: Day One report Supply Chain Management Systems New partnership for SC mechanism for PEPFAR It is a partnership made of profit and nonprofit NGOs and FBOs Meant to augment and support existing system: Not compete Wide consultation made and endorsed by many focus countries Not meant to create parallel system but work with public, faith based and private commercial organizations
PSM Technical Briefing Seminar: Day One report Happy Hour for the consultants – continued networking Long, windy and freezing walk to Adina Apartment Hotels Day one was done!
Thank you By Bannet & Sillo
3611bda0297945218300d9a34a5524cf.ppt